Evidence map›Paper›PMID 38615182›Full record

SynthesisAnnals of Saudi medicine

Metformin and risk of hematological cancers in patients with diabetes: a systematic review and meta-analysis.

Min Wang, Giti Noghabaei, Tahereh Raeisi, Dandan Li, Hamzeh Alizadeh, Mohammad Alizadeh

Open access · diamondAbstract readMeta-AnalysisSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Annals of Saudi medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Min WangFrom the Department of Endocrinology, Huaihe Hospital of Henan University, Kaifeng, Henan, China.
Giti NoghabaeiFrom the Department of Internal Medicine, Iran University of Medical Sciences, Tehran, Iran.
Tahereh RaeisiFrom the Department of Medicine, Hormozgan University of Medical Sciences, Bandar-Abbas, Iran.
Dandan LiFrom the Department of Endocrinology, Huaihe Hospital of Henan University, Kaifeng, Henan, China.ORCID 0009-0002-3358-3495
Hamzeh AlizadehFrom the Department of Genetics and Breeding, University of Guilan, Rasht, Gilan, Iran.
Mohammad AlizadehFrom the Department of Medical Surgical Nursing, Mazandaran University of Medical Sciences, Sari, Iran.
Henan University Huaihe Hospital and Huaihe Clinical Institute · CNHormozgan University of Medical Sciences · IRIran University of Medical Sciences · IRMazandaran University of Medical Sciences · IRUniversity of Guilan · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

fundingNo external funding.

Indexed as

Hematologic NeoplasmsHypoglycemic AgentsMetforminDiabetes MellitusDiabetes Mellitus, Type 2HumansRisk FactorsHypoglycemic AgentsMetformin

Identifiers

PMID38615182
PMCPMC11016148
OpenAlexW4394790226

What Socratic holds

Texttitle and abstract
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.